The Board of Lumito AB has decided to move the Annual General Meeting to 4 June
The Board of Lumito has decided to move the annual general meeting from 22 May to 4 June. The reason for the postponement is that the annual general meeting otherwise would have taken place in the middle of the subscription period for the new rights issue, as suggested by the Board. A notice convening the […]
Convocation of Extraordinary General Meeting of shareholders of Lumito AB (publ)
Shareholders of Lumito AB (publ), 556832-0062, are hereby convened to an Extraordinary General Meeting on Thursday, 25 April 2019, at 10:00 a.m. at Magistratsvägen 10, 226 43 Lund, Sweden. A. Right to participate at the Extraordinary General Meeting Shareholders who wish to participate at the extraordinary general meeting must be registered in the share […]
Convocation of Annual General Meeting of Lumito AB (publ)
Shareholders of Lumito AB (publ), Reg.no 556832-0062, are hereby convened to the Annual General Meeting on 4 June 2019, at 10:00 a.m., which will be held at the Company's premises at Gasverksgatan 1, 222 29 Lund, Sweden. Notification of participation Shareholders who wish to participate at the annual general meeting must: – be […]
Lumito – the first results from the new instrument prototype – significantly improved image quality.
Based on the results obtained from the concept phase, the new instrument prototype has been developed. Comparison made using the same microscope slides as the ones used in the concept phase with Lumito’s staining reagent shows significantly improved image quality. After the concept phase was completed during Q4 2018, phase two of the instrument and […]
Lumito presents results from the successful proof of concept phase
As previously disclosed the results from the first histological assay (Link to supporting material) (https://www.lumito.se/en/technology/concept-phase/) are very promising and corroborate a rapid development and release of Lumito’s unique products to the market. Lumito performed the assay together with the company’s development partner The Technology Partnership (TTP) and the external research laboratory BioIVT using proof of concept prototypes; tissue staining kit and instrument for […]
